Shots: Evotec to receive $6M payment from BMS to expand its partnership with the inclusion of additional cell lines In 2016, Evotec signed a 5-year research agreement with Celgene (now […]readmore
Tags : Agreement
Shots: Mithra to get up front, sales milestones, royalties and recurring revenues based on Minimal Annual Quantities (MAQ) and will manufacture Estelle at its Contract Development and Manufacturing Organization facility […]readmore
Shots: Mundipharma to get exclusive rights to market and distribute Biosolution’s CartiLife in South Korea. In May 2016, the companies signed commercialization agreement for allogeneic keratinocyte cell therapy product, KeraHeal-Allo […]readmore
Shots: Taiho and Astex to receive $50M up front, up to $2.5B milestones based on preclinical, clinical, regulatory and sales plus royalties on sales. Merck (MSD outside the United States […]readmore
Shots: Leap to receive $3M up front, up to $132M development, regulatory, and sales milestones plus royalties on sales of product. BeiGene to get an exclusive option to license DKN-01, […]readmore
Shots: Beacon will take care of drug discovery activities while Arena will focus on development and commercialization of products for multiple immune and inflammatory diseases The focus of the agreement […]readmore
Shots: Pulamtrix to receive $7.2M up front, milestones up to $2M on completion of P-Ib study of RV1162/PUR1800 for patients with COPD, with on-track for year-end 2020 from J&J’s Lung […]readmore
Shots: Amgen acquires 20.5% stake in BeiGene for ~$2.8B in cash, with $174.85/share representing 36% premium. BeiGene will commercialize Xgeva, Kyprolis, and Blincyto in China with equal profit-loss sharing while […]readmore
Shots: Roche and Sensyne Health collaborate to apply AI technology for clinical trial designs and will further strengthen Roche’s approach in data and technology-driven personalized healthcare The collaboration will focus […]readmore
Shots: GenScript will be responsible for all pre-clinical pharmacy research and IND filling in Selecxine’s project which is based on cytokine-antibody complexes The company provided development solutions in different hosts […]readmore